2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Bcg: new trials by email Literature Review of Bcg trials Research Report on Bcg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) BCG for Therapeutic Use - Non-Muscle Invasive Bladder Cancer | Phase 3 | Unknown | Chengdu CoenBiotech Co., Ltd | 412 | 2023-12-28 | 2024-02-05 |
| Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer BCG instillation therapy, Sequential BCG and EMDA mitomycin C - Bladder Cancer | Phase 3 | Unknown | Turku University Hospital | 300 | 2018-10-26 | 2021-04-01 |
Urinary Bladder Neoplasms (2) · Non-Muscle Invasive Bladder Neoplasms (1) · Recurrence (1)
Chengdu CoenBiotech Co., Ltd (1) · Turku University Hospital (1)
China (1) · Finland (1)